UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (534) 534
science & technology (529) 529
life sciences & biomedicine (528) 528
oncology (392) 392
female (388) 388
male (329) 329
adult (287) 287
middle aged (267) 267
chemotherapy (255) 255
hematology (227) 227
high-dose methotrexate (223) 223
biological and medical sciences (218) 218
medical sciences (218) 218
antineoplastic combined chemotherapy protocols - therapeutic use (201) 201
high-dose chemotherapy (200) 200
methotrexate - administration & dosage (189) 189
methotrexate (169) 169
treatment outcome (162) 162
adolescent (156) 156
aged (152) 152
cancer (141) 141
pharmacology. drug treatments (141) 141
antineoplastic agents (126) 126
child (118) 118
combined modality therapy (115) 115
dose-response relationship, drug (111) 111
antineoplastic combined chemotherapy protocols - administration & dosage (110) 110
retrospective studies (108) 108
disease-free survival (97) 97
medicine & public health (97) 97
methotrexate - adverse effects (97) 97
transplantation (97) 97
prognosis (95) 95
antineoplastic combined chemotherapy protocols - adverse effects (89) 89
cyclophosphamide - administration & dosage (86) 86
hematopoietic stem cell transplantation (86) 86
child, preschool (84) 84
follow-up studies (83) 83
care and treatment (80) 80
transplantation, autologous (80) 80
stem cells (78) 78
lymphomas (77) 77
pediatrics (77) 77
survival rate (69) 69
dosage and administration (65) 65
survival analysis (64) 64
methotrexate - therapeutic use (61) 61
hematologic and hematopoietic diseases (59) 59
high‐dose chemotherapy (59) 59
recurrence (58) 58
antimetabolites, antineoplastic - administration & dosage (57) 57
pharmacology & pharmacy (57) 57
high dose methotrexate (55) 55
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (55) 55
stem cell transplantation (55) 55
breast cancer (54) 54
central nervous system neoplasms - drug therapy (53) 53
remission induction (53) 53
breast neoplasms - drug therapy (52) 52
osteosarcoma (52) 52
osteosarcoma - drug therapy (51) 51
tumors (51) 51
cytarabine - administration & dosage (50) 50
lymphoma (50) 50
doxorubicin - administration & dosage (49) 49
drug administration schedule (49) 49
rituximab (49) 49
young adult (49) 49
infant (48) 48
analysis (47) 47
etoposide - administration & dosage (47) 47
high‐dose methotrexate (47) 47
risk factors (47) 47
cisplatin - administration & dosage (46) 46
vincristine - administration & dosage (46) 46
antimetabolites, antineoplastic - adverse effects (45) 45
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (45) 45
toxicity (45) 45
central nervous system (44) 44
primary central nervous system lymphoma (44) 44
radiotherapy (43) 43
autologous stem cell transplantation (41) 41
cyclophosphamide (41) 41
acute lymphoblastic leukemia (39) 39
children (39) 39
lymphoma, non-hodgkin - drug therapy (39) 39
lymphoma - drug therapy (38) 38
patients (38) 38
research (38) 38
neurosciences & neurology (37) 37
salvage therapy (37) 37
bone neoplasms - drug therapy (36) 36
clinical neurology (35) 35
combined treatments (35) 35
neoplasm staging (35) 35
antimetabolites, antineoplastic - therapeutic use (33) 33
breast neoplasms - therapy (33) 33
high-dose therapy (33) 33
immunology (33) 33
primary cns lymphoma (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (764) 764
Japanese (32) 32
German (13) 13
French (8) 8
Russian (5) 5
Polish (3) 3
Korean (2) 2
Spanish (2) 2
Turkish (2) 2
Hungarian (1) 1
Persian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The oncologist (Dayton, Ohio), ISSN 1083-7159, 12/2016, Volume 21, Issue 12, pp. 1471 - 1482
Journal Article